Institutional Ownership Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX). We have compiled data on the 188 institutions that hold shares in the stock, with a total of 69.3 Million shares, which have been reported (via 13F filing form) to have a value of $1.38 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Redmile Group, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
590,175
shares
|
$11.8 Million
1.13% of portfolio
|
Q1 2025
Reduced 4.16%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
577,361
shares
|
$11.5 Million
0.0% of portfolio
|
Q1 2025
Reduced 3.39%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
535,844
shares
|
$10.7 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.56%
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
May 15, 2025 Q1 2025 |
507,829
shares
|
$10.1 Million
2.43% of portfolio
|
Q1 2025
Added 7.11%
|
|
5 Am Venture Management, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
497,270
shares
|
$9.92 Million
6.25% of portfolio
|
Q4 2023
Added 60.27%
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
429,126
shares
|
$8.56 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2025 Q1 2025 |
406,161
shares
|
$8.1 Million
0.01% of portfolio
|
Q1 2025
Reduced 21.64%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
399,932
shares
|
$7.98 Million
0.0% of portfolio
|
Q1 2025
Added 327.27%
|
|
Tsp Capital Management Group, LLC
|
May 15, 2025 Q1 2025 |
335,977
shares
|
$6.7 Million
2.18% of portfolio
|
Q1 2025
Added 50.43%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
288,378
shares
|
$5.75 Million
0.0% of portfolio
|
Q4 2024
Reduced 20.7%
|
|
Tfg Asset Management Gp LTD
Grand Cayman, E9 |
May 15, 2025 Q1 2025 |
261,000
shares
|
$5.21 Million
1.37% of portfolio
|
Q1 2025
Added 35.94%
|
|
Baker Bros. Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
247,644
shares
|
$4.94 Million
0.05% of portfolio
|
Q4 2023
New holding
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
244,936
shares
|
$4.89 Million
0.0% of portfolio
|
Q1 2025
Added 471.64%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
241,354
shares
|
$4.82 Million
0.0% of portfolio
|
Q1 2025
Added 182.14%
|
|
Natixis
Paris, I0 |
May 14, 2025 Q1 2025 |
232,188
shares
|
$4.63 Million
0.02% of portfolio
|
Q1 2025
Added 1369.54%
|
|
Jane Street Group, LLC
New York, NY |
May 19, 2025 Q1 2025 |
214,426
shares
|
$4.28 Million
0.0% of portfolio
|
Q1 2025
Added 150.55%
|
|
Silverarc Capital Management, LLC
|
May 14, 2025 Q1 2025 |
205,962
shares
|
$4.11 Million
0.91% of portfolio
|
Q1 2025
Reduced 22.15%
|
|
Vestal Point Capital, LP
New York, NY |
May 15, 2025 Q1 2025 |
198,646
shares
|
$3.96 Million
0.26% of portfolio
|
Q1 2025
Reduced 34.87%
|
|
Axa S.A.
Paris, I0 |
May 15, 2025 Q1 2025 |
184,803
shares
|
$3.69 Million
0.01% of portfolio
|
Q1 2025
Reduced 0.13%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
146,588
shares
|
$2.92 Million
0.0% of portfolio
|
Q1 2025
Added 7.32%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
138,289
shares
|
$2.76 Million
0.0% of portfolio
|
Q1 2025
Added 13.82%
|
|
Algert Global LLC
San Francisco, CA |
May 13, 2025 Q1 2025 |
133,597
shares
|
$2.67 Million
0.06% of portfolio
|
Q1 2025
Added 28.04%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 19, 2025 Q1 2025 |
131,296
shares
|
$2.62 Million
0.0% of portfolio
|
Q1 2025
Added 12.88%
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
130,688
shares
|
$2.61 Million
0.0% of portfolio
|
Q1 2025
Added 9.49%
|
|
Mirador Capital Partners LP
|
Apr 08, 2025 Q1 2025 |
127,874
shares
|
$2.55 Million
0.48% of portfolio
|
Q1 2025
Added 7.01%
|